PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
358.00
-4.00 (-1.10%)
At close: Jul 14, 2025, 3:30 PM WIB

IDX:OBAT Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
124,991120,62756,93038,49637,853
Revenue Growth (YoY)
73.71%111.89%47.89%1.70%-
Cost of Revenue
65,94864,20634,57819,02214,872
Gross Profit
59,04356,42122,35219,47422,981
Selling, General & Admin
20,28618,5327,7515,7524,498
Other Operating Expenses
-266.62110.2694.21110.23188.84
Operating Expenses
20,01918,6437,8455,8624,687
Operating Income
39,02437,77814,50713,61118,294
Interest Expense
-1,511-1,381-1,253-845.28-279.34
Interest & Investment Income
2,6742,6741,8221,369750.66
Earnings From Equity Investments
588.56406.25-250.26--
Other Non Operating Income (Expenses)
33.6152.54-1.45-2.611.74
EBT Excluding Unusual Items
40,81039,53114,82414,13318,767
Asset Writedown
-3.83-3.83-66.98-2.97-7.76
Other Unusual Items
--337.11816.75731.4
Pretax Income
40,80639,52715,09414,94619,491
Income Tax Expense
9,0289,0283,1863,3224,184
Earnings From Continuing Operations
31,77830,49911,90811,62515,307
Minority Interest in Earnings
-1,144-1,07365.94759.76342.69
Net Income
30,63529,42611,97412,38415,649
Net Income to Common
30,63529,42611,97412,38415,649
Net Income Growth
99.99%145.75%-3.32%-20.86%-
Shares Outstanding (Basic)
600600430463463
Shares Outstanding (Diluted)
600600430463463
Shares Change (YoY)
29.24%39.53%-7.13%--
EPS (Basic)
51.0649.0427.8526.7533.80
EPS (Diluted)
51.0649.0427.8526.7533.80
EPS Growth
54.74%76.12%4.10%-20.86%-
Free Cash Flow
-6,1666,3556,5287,14814,908
Free Cash Flow Per Share
-10.2810.5915.1815.4432.20
Dividend Per Share
22.37022.37016.95032.40017.280
Dividend Growth
31.98%31.98%-47.69%87.50%-
Gross Margin
47.24%46.77%39.26%50.59%60.71%
Operating Margin
31.22%31.32%25.48%35.36%48.33%
Profit Margin
24.51%24.39%21.03%32.17%41.34%
Free Cash Flow Margin
-4.93%5.27%11.47%18.57%39.38%
EBITDA
41,28939,97416,58214,87519,026
EBITDA Margin
33.03%33.14%29.13%38.64%50.26%
D&A For EBITDA
2,2652,1962,0751,263731.94
EBIT
39,02437,77814,50713,61118,294
EBIT Margin
31.22%31.32%25.48%35.36%48.33%
Effective Tax Rate
22.12%22.84%21.11%22.23%21.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.